NYSE: SPCE

Virgin Galactic Holdings, Inc

CIK 0001706946 · SIC 4700 · Transportation Services

Micro by revenue · Mid by assets Revenue $2M Assets $816M as of Nov 1, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (YELP 10-Q) is open in full — no account needed.

8-K Filed Nov 13, 2026 · Period ending Nov 13, 2026

Summary not yet generated.

424B5 Filed Nov 12, 2026

Summary not yet generated.

Partner

Trade SPCE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Nov 12, 2026 · Period ending Nov 12, 2026

Summary not yet generated.

10-Q Filed Nov 12, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Aug 18, 2026 · Period ending Aug 18, 2026

Summary not yet generated.

10-Q Filed Aug 12, 2026 · Period ending Jun 30, 2026 Critical

revenue $134,000, net income -$55.9M. Virgin Galactic flags going-concern doubt, delays commercial service to Feb 2027

5 material changes detected. Sign up free to read the summary.

8-K Filed Aug 12, 2026 · Period ending Aug 12, 2026

Virgin Galactic delays first commercial flight to Feb 2027, books $50M+ in new revenue

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 22, 2026 · Period ending Jun 22, 2026

Virgin Galactic exchanges $52.5M of 2027 convertible notes for stock, cutting debt 75%

3 material changes detected. Sign up free to read the summary.

8-K Filed Jun 15, 2026 · Period ending Jun 11, 2026

Virgin Galactic shareholders approve 9.45M share increase for employee equity compensation

4 material changes detected. Sign up free to read the summary.

8-K Filed Jun 10, 2026 · Period ending Jun 10, 2026

Virgin Galactic redeems $30.5M debt with 6.7M shares, cuts interest burden ahead of Q4 launch

3 material changes detected. Sign up free to read the summary.

8-K Filed Jun 2, 2026 · Period ending Jun 2, 2026

Virgin Galactic redeems $30.5M debt via stock issuance to eliminate principal payments through 2027

4 material changes detected. Sign up free to read the summary.

8-K Filed May 28, 2026 · Period ending May 28, 2026 Red flag

Virgin Galactic settles 2022 stockholder derivative lawsuits, final approval hearing July 28

3 material changes detected. Sign up free to read the summary.

8-K Filed May 18, 2026 · Period ending May 18, 2026

Virgin Galactic redeems $10M debt with 3.8M shares, cuts interest ahead of Q4 launch

3 material changes detected. Sign up free to read the summary.

8-K Filed May 14, 2026 · Period ending May 14, 2026

Virgin Galactic reports Q1 2026 financial results

2 material changes detected. Sign up free to read the summary.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026 Critical

revenue $227,000, net income -$64.7M. Virgin Galactic flags going-concern doubt as cash falls 23.4%, delays commercial restart to Q4

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 30, 2026 · Period ending Apr 30, 2026

Virgin Galactic to redeem $10M debt with stock, faces $30M mandatory payment by September

4 material changes detected. Sign up free to read the summary.

8-K Filed Apr 24, 2026 · Period ending Apr 24, 2026

Virgin Galactic amends debt indenture to gain flexibility on note redemptions

3 material changes detected. Sign up free to read the summary.

8-K Filed Apr 21, 2026 · Period ending Apr 21, 2026

Virgin Galactic boosts CFO severance 50% in change-of-control scenarios

3 material changes detected. Sign up free to read the summary.

10-Q Filed Nov 13, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 6, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed May 15, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 12, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(Unaudited; in thousands, except per share amounts)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Revenue 427 365 788 1,232
Operating expenses:
Spaceline operations 28,272 19,497 86,094 54,529
Research and development 2,567 14,952 13,618 68,383
Selling, general and administrative 24,493 27,965 78,600 90,365
Depreciation and amortization 4,089 4,117 11,988 12,511
Total operating expenses 59,421 66,531 190,300 225,788
Operating loss (58,994) (66,166) (189,512) (224,556)
Interest income 1,979 4,966 7,076 18,013
Interest expense (1,732) (3,250) (5,554) (9,737)
Gain on extinguishment of debt — — 8,639 —
Other income, net 21 33 81 107
Loss before income taxes (58,726) (64,417) (179,270) (216,173)
Income tax expense 30 — 90 11
Net loss (58,756) (64,417) (179,360) (216,184)
Other comprehensive loss:
Foreign currency translation adjustment 1 (6) (9) 12
Unrealized gain (loss) on marketable securities 9 239 (57) (71)
Total comprehensive loss (58,746) (64,184) (179,426) (216,243)
Net loss per share:
Basic and diluted (0.39) (1.09) (1.57) (4.61)
Weighted-average shares outstanding:
Basic and diluted 151,596 59,252 114,209 46,865

Condensed Consolidated Balance Sheets (Unaudited)

(Unaudited; in thousands, except share and per share amounts)

Description September 30, 2026 December 31, 2025
Assets
Current assets:
Cash and cash equivalents 144,007 144,727
Restricted cash 31,293 30,988
Marketable securities 8,991 162,313
Other current assets 26,022 34,870
Total current assets 210,313 372,898
Property, plant and equipment, net 500,329 388,730
Other non-current assets 36,381 41,551
Total assets 747,023 803,179
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable 17,886 15,163
Current portion of long-term debt 30,098 47,830
Customer deposits 80,460 78,535
Other current liabilities 52,557 67,795
Total current liabilities 181,001 209,323
Non-current liabilities:
Long-term debt 186,242 276,362
Other long-term liabilities 36,278 43,530
Total liabilities 403,521 529,215
Commitments and contingencies (Note 14)
Stockholders’ Equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding — —
Common stock, $0.0001 par value; 700,000,000 shares authorized; 151,601,493 and 73,326,504 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 15 7
Additional paid-in capital 3,274,560 3,025,604
Accumulated deficit (2,931,139) (2,751,779)
Accumulated other comprehensive income 66 132
Total stockholders’ equity 343,502 273,964
Total liabilities and stockholders’ equity 747,023 803,179

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Unaudited; in thousands)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Cash flows from operating activities:
Net loss (179,360) (216,184)
Stock-based compensation 17,092 14,320
Depreciation and amortization 11,988 12,511
Gain on extinguishment of debt (8,639) —
Amortization of debt issuance costs 1,187 1,721
Accretion of marketable securities purchased at a discount (1,149) (5,380)
Other non-cash items (11) (18)
Change in operating assets and liabilities:
Other current and non-current assets 6,914 (4,393)
Accounts payable 977 5,014
Customer deposits 1,925 (4,295)
Other current and non-current liabilities (12,643) 9,037
Net cash used in operating activities (161,719) (187,667)
Cash flows from investing activities:
Capital expenditures (121,468) (155,892)
Purchases of marketable securities (72,081) (306,754)
Proceeds from maturities and calls of marketable securities 226,499 492,505
Other investing activities 10 8
Net cash provided by investing activities 32,960 29,867
Cash flows from financing activities:
Payments of long-term debt (11,170) —
Payments of finance lease obligations (179) (154)
Proceeds from issuance of common stock pursuant to at-the-market offering 145,020 109,160
Transaction costs related to issuance of common stock pursuant to at-the-market offering (3,748) (3,179)
Other debt and equity transaction costs (247) —
Proceeds from issuance of common stock pursuant to employee stock purchase plan 476 —
Withholding taxes paid on behalf of employees on net settled stock-based awards (1,808) (118)
Net cash provided by financing activities 128,344 105,709
Net decrease in cash, cash equivalents and restricted cash (415) (52,091)
Cash, cash equivalents and restricted cash at beginning of period 175,715 210,885
Cash, cash equivalents and restricted cash at end of period 175,300 158,794
Cash and cash equivalents 144,007 128,789
Restricted cash 31,293 30,005
Cash, cash equivalents and restricted cash 175,300 158,794

Amounts as printed on the EDGAR/iXBRL face — (Unaudited; in thousands, except per share amounts); (Unaudited; in thousands, except share and per share amounts); (Unaudited; in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗